<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03398655</url>
  </required_header>
  <id_info>
    <org_study_id>VB-111-701/GOG-3018</org_study_id>
    <nct_id>NCT03398655</nct_id>
  </id_info>
  <brief_title>A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL)</brief_title>
  <acronym>OVAL</acronym>
  <official_title>A Randomized, Controlled, Double-Arm, Double-Blind, Multi-Center Study of Ofranergene Obadenovec (VB-111) Combined With Paclitaxel vs. Paclitaxel Combined With Placebo for the Treatment of Recurrent Platinum-Resistant Ovarian Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vascular Biogenics Ltd. operating as VBL Therapeutics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>GOG Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Vascular Biogenics Ltd. operating as VBL Therapeutics</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this phase 3, randomized, multicenter study is to compare VB-111 and&#xD;
      paclitaxel to placebo and paclitaxel in adult patients with Recurrent Platinum-Resistant&#xD;
      Ovarian Cancer.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 19, 2017</start_date>
  <completion_date type="Anticipated">June 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overall Survival</measure>
    <time_frame>From randomization until death from any cause (up to 5 years after last study treatment)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Progression Free Survival (PFS) by RECIST 1.1</measure>
    <time_frame>From randomization until progression defined according to RECIST 1.1 or death, whichever occurs first (up to 5 years after last study treatment)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Combined CA-125 and RECIST 1.1 response (GCIG)</measure>
    <time_frame>From date of study entry until the date of death from any cause, or up to 5 years after last study treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CA-125 Response (GCIG)</measure>
    <time_frame>From date of study entry until the date of death from any cause, or up to 5 years after last study treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Objective response rate (ORR) by RECIST 1.1</measure>
    <time_frame>From date of study entry until the date of death from any cause, or up to 5 years after last study treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>OS100 for a sensitivity analysis of OS</measure>
    <time_frame>From 100 days after date of study entry until the date of death from any cause, or up to 5 years after last study treatment</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Recurrent Platinum Resistant Ovarian Cancer</condition>
  <arm_group>
    <arm_group_label>Arm 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>VB-111 + Paclitaxel</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Placebo + Paclitaxel</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>VB-111 + Paclitaxel</intervention_name>
    <description>VB-111 will be administered intravenously at a dose of 1x10e13 VPs every 2 months Paclitaxel will be administered intravenously at a dose of 80mg/m2 every week</description>
    <arm_group_label>Arm 1</arm_group_label>
    <other_name>Ofranergene Obadenovec</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo + Paclitaxel</intervention_name>
    <description>Placebo will be administered intravenously every 2 months Paclitaxel will be administered intravenously at a dose of 80mg/m2 every week</description>
    <arm_group_label>Arm 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Female patients ≥18 years of age&#xD;
&#xD;
          2. Histologically confirmed epithelial ovarian cancer and documented disease.&#xD;
&#xD;
          3. Patients must have platinum-resistant disease&#xD;
&#xD;
          4. Patients must have disease that is measurable according to RECIST 1.1 and require&#xD;
             chemotherapy treatment.&#xD;
&#xD;
          5. ECOG PS 0-1.&#xD;
&#xD;
          6. Adequate hematological functions:&#xD;
&#xD;
               -  ANC ≥ 1000/mm3&#xD;
&#xD;
               -  PLT ≥ 100,000/mm3&#xD;
&#xD;
               -  PT and PTT (seconds) &lt; 1.2 X ULN. Patients who are anticoagulated do not need to&#xD;
                  meet criteria for PT and PTT.&#xD;
&#xD;
          7. Patients who are known to carry a BRCA mutation may be enrolled only after (following&#xD;
             PARP inhibitor treatment failure, or being intolerant of, or ineligible for PARP&#xD;
             inhibitor treatment).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Non-epithelial tumors (Carcino-sarcomas are excluded)&#xD;
&#xD;
          2. Ovarian tumors with low malignant potential (i.e. borderline tumors) clear cell&#xD;
             carcinomas, grade 1 serous tumors or mucinous tumors.&#xD;
&#xD;
          3. History of other clinically active malignancy within 5 years of enrollment, except for&#xD;
             tumors with a negligible risk for metastasis or death, such as adequately controlled&#xD;
             basal-cell carcinoma, adequately controlled, non-metastatic squamous-cell carcinoma of&#xD;
             the skin, or carcinoma in situ of the cervix or breast.&#xD;
&#xD;
          4. Previous ovarian cancer treatment with &gt;5 anticancer regimens.&#xD;
&#xD;
          5. Any prior radiotherapy to the pelvis or whole abdomen.&#xD;
&#xD;
          6. Inadequate liver function, defined as serum creatinine &gt; ULN, unless calculated&#xD;
             creatinine clearance &gt; 50ml/min (by Cockroft &amp; Gault formula):&#xD;
&#xD;
               -  Serum (total) bilirubin &gt; ULN (Exception: documented Gilbert's disease patients&#xD;
                  can be enrolled)&#xD;
&#xD;
               -  Alkaline phosphatase, AST/SGOT or ALT/SGPT ≥2.5 x ULN (or ≥ 5 x ULN in the&#xD;
                  presence of liver metastases).&#xD;
&#xD;
          7. Inadequate renal function, defined as:&#xD;
&#xD;
               -  Serum creatinine &gt; ULN OR&#xD;
&#xD;
               -  Calculated creatinine clearance &lt; 50ml/min (by Cockroft &amp; Gault formula)&#xD;
&#xD;
          8. New York Heart Association (NYHA) Grade II or greater congestive heart failure&#xD;
&#xD;
          9. History of myocardial infarction or unstable angina within 6 months prior to day of&#xD;
             randomization.&#xD;
&#xD;
         10. History of stroke or transient ischemic attack within 6 months prior to day of&#xD;
             randomization.&#xD;
&#xD;
         11. Patient with proliferative and/or vascular retinopathy&#xD;
&#xD;
         12. Known brain metastases&#xD;
&#xD;
         13. History of hemoptysis or active GI bleeding within 6 month prior to day of&#xD;
             randomization&#xD;
&#xD;
         14. Evidence of bleeding diathesis or significant coagulopathy (in the absence of&#xD;
             therapeutic anticoagulation).&#xD;
&#xD;
         15. History of abdominal fistula or gastrointestinal perforation.&#xD;
&#xD;
         16. Current signs and symptoms of bowel obstruction&#xD;
&#xD;
         17. Uncontrolled active infection&#xD;
&#xD;
         18. Patients who had evidence of disease progression during or up to 90 days from the last&#xD;
             dose of the first line of platinum based therapy&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Shifra Fain-Shmueli</last_name>
    <phone>972-8-9935000</phone>
    <email>shifra@vblrx.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>UAB Division of GYN Oncology</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35344</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Wilbanks</last_name>
      <phone>205-934-6454</phone>
      <email>asb2013@uab.edu</email>
    </contact>
    <investigator>
      <last_name>Rebecca Arend, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Western Regional Medical Center</name>
      <address>
        <city>Goodyear</city>
        <state>Arizona</state>
        <zip>85338</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Veta L. Clayton</last_name>
      <phone>623-207-3310</phone>
      <email>Veta.Clayton@ctca-hope.com</email>
    </contact>
    <investigator>
      <last_name>John H Farley, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Arizona Oncology Associates, PC - HAL - USO</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karen Walsh</last_name>
      <phone>281-863-2586</phone>
      <email>karen.walsh@usoncology.com</email>
    </contact>
    <investigator>
      <last_name>Bradley Monk, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Arizona Oncology Associates, PC - HAL - USO</name>
      <address>
        <city>Tempe</city>
        <state>Arizona</state>
        <zip>85284</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ana Flores</last_name>
      <phone>480-256-1664</phone>
      <email>ana.flores@usoncology.com</email>
    </contact>
    <contact_backup>
      <last_name>Elena Rivers</last_name>
      <phone>480-256-1664</phone>
      <email>elena.rivers@usoncology.com</email>
    </contact_backup>
    <investigator>
      <last_name>Bradley Monk, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Arizona Cancer Center</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85719</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yrma Burruel</last_name>
      <phone>520-694-9081</phone>
      <email>yburruel@uacc.arizona.edu</email>
    </contact>
    <investigator>
      <last_name>Setsuko Chambers, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UCLA-JCCC-Women's Health Clinical Research Unit</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sonali S Namiranian</last_name>
      <phone>310-794-9095</phone>
      <email>snamiranian@mednet.ucla.edu</email>
    </contact>
    <investigator>
      <last_name>Joshua Cohen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Center for Cancer Prevention and Treatment at St. Joseph Hospital of Orange</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92868</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lavinia Dobrea</last_name>
      <phone>714-734-6220</phone>
      <email>Lavinia.Dobrea@stjoe.org</email>
    </contact>
    <investigator>
      <last_name>Tariq Mahmood, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California, Irvine Medical Center/Chao Family Comprehensive Cancer Center</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92868</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Idelfonso</last_name>
      <phone>714-509-2261</phone>
      <email>midelfon@uci.edu</email>
    </contact>
    <investigator>
      <last_name>Krishnansu Tewari, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California - San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94158</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katherine Bigay</last_name>
      <phone>415-885-7206</phone>
      <email>Katherine.Bigay@ucsf.edu</email>
    </contact>
    <investigator>
      <last_name>Edwin Alvarez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sansum Clinic - USO</name>
      <address>
        <city>Santa Barbara</city>
        <state>California</state>
        <zip>93105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heidi Heitkamp</last_name>
      <phone>281-863-2586</phone>
      <email>hheitkam@ridleytreecc.org</email>
    </contact>
    <investigator>
      <last_name>Thomas Woliver, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Olive View UCLA Medical Center</name>
      <address>
        <city>Sylmar</city>
        <state>California</state>
        <zip>91342</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bianca Alcantar</last_name>
      <phone>747-210-4529</phone>
      <email>bialcantar@dhs.lacounty.gov</email>
    </contact>
    <contact_backup>
      <last_name>Brooke Benavides</last_name>
      <phone>747-210-8812</phone>
      <email>bbenavides@dhs.lacounty.gov</email>
    </contact_backup>
    <investigator>
      <last_name>Christine Holschneider, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hartford HealthCare Cancer Institute at the Hospital of Central Ct</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06053</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sara Putala</last_name>
      <phone>860-972-5018</phone>
      <email>sara.putala@hhchealth.org</email>
    </contact>
    <investigator>
      <last_name>Amy B rown, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hartford Healthcare</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sara Putala</last_name>
      <phone>860-972-5018</phone>
      <email>sara.putala@hhchealth.org</email>
    </contact>
    <investigator>
      <last_name>Amy B rown, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UF Health</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Lynn</last_name>
      <phone>352-265-0680</phone>
      <phone_ext>87658</phone_ext>
      <email>Melissa.Lynn@medicine.ufl.edu</email>
    </contact>
    <investigator>
      <last_name>Merry Markham, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonio Marrero</last_name>
      <phone>305-243-6248</phone>
      <email>axm2830@med.miami.edu</email>
    </contact>
    <investigator>
      <last_name>Marilyn Huang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stacey Worrell</last_name>
      <phone>404-778-5311</phone>
      <email>stacey.worrell@emory.edu</email>
    </contact>
    <investigator>
      <last_name>Namita Khanna, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lois Winkelman</last_name>
      <phone>312-942-2417</phone>
      <email>lois_a_winkelman@rush.edu</email>
    </contact>
    <investigator>
      <last_name>Jean-Marie Stephan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Carle Cancer Center</name>
      <address>
        <city>Urbana</city>
        <state>Illinois</state>
        <zip>61801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle Sedberry</last_name>
      <phone>217-326-0281</phone>
      <email>michelle.sedberry@carle.com</email>
    </contact>
    <investigator>
      <last_name>Maria Grosse-Perdekamp, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Midwestern Regional Medical Center, Inc</name>
      <address>
        <city>Zion</city>
        <state>Illinois</state>
        <zip>60099</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cliona McAlister</last_name>
      <phone>847-731-1777</phone>
      <email>Cliona.mcalister@ctca-hope.com</email>
    </contact>
    <investigator>
      <last_name>Julian Schink, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Parkview Cancer Institute</name>
      <address>
        <city>Fort Wayne</city>
        <state>Indiana</state>
        <zip>46845</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tracy Thorne</last_name>
      <phone>260-266-7764</phone>
      <email>Tracy.Thorne@parkview.com</email>
    </contact>
    <investigator>
      <last_name>Iwona Podzielinski, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Indiana University School of Medicine</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46131</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rachel Alvey</last_name>
      <phone>317-278-6455</phone>
      <email>rlalvey@iu.edu</email>
    </contact>
    <investigator>
      <last_name>Paul Mayor, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Vincent Gynecologic Oncology</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46260</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cynthia E Cruz</last_name>
      <phone>317-415-6747</phone>
      <email>cynthia.cruzrivera@ascension.org</email>
    </contact>
    <investigator>
      <last_name>Michael Callahan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Kansas Cancer Center</name>
      <address>
        <city>Westwood</city>
        <state>Kansas</state>
        <zip>66205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jmaes Jeffery</last_name>
      <phone>913-945-8871</phone>
      <email>jjeffery2@kumc.edu</email>
    </contact>
    <investigator>
      <last_name>Andrea Jewell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Kentucky</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40536</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shar Ellixson</last_name>
      <phone>859-323-3975</phone>
      <email>swelli2@uky.edu</email>
    </contact>
    <investigator>
      <last_name>Frederick Ueland, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ochsner Clinic Foundation</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70121</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicole Duffaut</last_name>
      <phone>504-842-2447</phone>
      <email>nicole.duffaut@ochsner.org</email>
    </contact>
    <investigator>
      <last_name>Katrina Wade, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Maryland</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nancy Tait</last_name>
      <phone>410-328-3546</phone>
      <email>ntait@umm.edu</email>
    </contact>
    <contact_backup>
      <last_name>Janie Wangdali</last_name>
      <phone>410-328-3546</phone>
      <email>jwangdali@umm.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Dana M Roque, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Holy Cross Hospital</name>
      <address>
        <city>Silver Spring</city>
        <state>Maryland</state>
        <zip>20902</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lyudmila Kalnitskaya</last_name>
      <phone>301-754-7552</phone>
      <email>kalnitsl@holycrosshealth.org</email>
    </contact>
    <investigator>
      <last_name>James Barter, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>20114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jesse Sardell</last_name>
      <phone>617-643-4088</phone>
      <email>jsardell@mgh.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Richard Penson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>04801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caitlin McCarthy</last_name>
      <phone>734-615-5118</phone>
      <email>caitlimc@med.umich.edu</email>
    </contact>
    <investigator>
      <last_name>Jean Siedel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Karmanos Cancer Institute</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jasmine Hunt</last_name>
      <phone>313-576-9382</phone>
      <email>huntj@karmanos.org</email>
    </contact>
    <investigator>
      <last_name>Shelly Morris, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Henry Ford Health Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marbybeth McCarthy</last_name>
      <phone>313-916-7827</phone>
      <email>mmccart2@hfhs.org</email>
    </contact>
    <investigator>
      <last_name>Irina Dimitrova, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dartmouth- Hitchcock Medical Center</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacqueline M. Kihwele</last_name>
      <phone>603-653-9056</phone>
      <email>Jacqueline.M.Kihwele@hitchcock.org</email>
    </contact>
    <investigator>
      <last_name>Evelyn Fleming, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Atlantic Health System/Morristown Medical Center</name>
      <address>
        <city>Morristown</city>
        <state>New Jersey</state>
        <zip>07928</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nancy Ginder</last_name>
      <phone>973-971-6608</phone>
      <email>nancy.ginder@atlantichealth.org</email>
    </contact>
    <investigator>
      <last_name>Nana Tchabo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rutgers New Jersey Medical School</name>
      <address>
        <city>Newark</city>
        <state>New Jersey</state>
        <zip>07103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Randall Teeter</last_name>
      <phone>973-972-8367</phone>
      <email>randall.teeter@njms.rutgers.edu</email>
    </contact>
    <investigator>
      <last_name>Mark H Einstein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New Mexico Cancer Care Alliance</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sheri Westgate</last_name>
      <phone>505-925-0383</phone>
      <email>swestgate@salud.unm.edu</email>
    </contact>
    <investigator>
      <last_name>Carolyn Muller, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Women's Cancer Care Associates, LLC</name>
      <address>
        <city>Albany</city>
        <state>New York</state>
        <zip>12208</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kim Fredericks</last_name>
      <phone>518-458-1390</phone>
      <email>kfredericks@womenscancercareassociates.com</email>
    </contact>
    <investigator>
      <last_name>Joyce Barlin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Westchester Medical Center</name>
      <address>
        <city>Hawthorne</city>
        <state>New York</state>
        <zip>10532</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Judy Moore</last_name>
      <phone>914-533-4115</phone>
      <email>judy.moore@wmchealth.org</email>
    </contact>
    <investigator>
      <last_name>Ama Buskwofie</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwell Health Cancer Institute</name>
      <address>
        <city>Lake Success</city>
        <state>New York</state>
        <zip>11042</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Templeton</last_name>
      <phone>516-734-8979</phone>
      <email>Mtempleton@northwell.edu</email>
    </contact>
    <investigator>
      <last_name>Veena John, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Laura and Isaac Perlmutter Cancer Center at NYU Langone</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nancy Keith</last_name>
      <phone>929-455-2422</phone>
      <email>nancy.keith@nyulangone.edu</email>
    </contact>
    <investigator>
      <last_name>Douglas Levine, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Health Quest Medical Practice, Division of Gynecology/Oncology Gyno Dyson Cancer Center Vassar Brothers Medical Center</name>
      <address>
        <city>Poughkeepsie</city>
        <state>New York</state>
        <zip>12601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raminder Chadha</last_name>
      <phone>845-483-6456</phone>
      <email>rchadha@Health-quest.org</email>
    </contact>
    <investigator>
      <last_name>Heidi Godoy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>SUNY Upstate Medical University</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vanessa Gatmaitan</last_name>
      <phone>315-464-5788</phone>
      <email>GatmaitV@upstate.edu</email>
    </contact>
    <investigator>
      <last_name>Mary Cunningham, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UNC Chapel Hill</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27707</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Gruhn</last_name>
      <phone>919-445-4212</phone>
      <email>jennifer_gruhn@med.unc.edu</email>
    </contact>
    <investigator>
      <last_name>Linda Van Le, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Duke University-Duke Cancer Institute</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kara Hagler</last_name>
      <phone>919-684-3780</phone>
      <email>kara.hagler@duke.edu</email>
    </contact>
    <investigator>
      <last_name>Angeles Secord, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wake Forest Baptist Medical Center</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cindy Miller</last_name>
      <phone>336-713-6770</phone>
      <email>cytmill@wakehealth.edu</email>
    </contact>
    <investigator>
      <last_name>Samuel Lentz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sanford Medical Center</name>
      <address>
        <city>Fargo</city>
        <state>North Dakota</state>
        <zip>58122</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ellen Dierking</last_name>
      <phone>701-234-5688</phone>
      <email>ellen.dierking@sanfordhealth.org</email>
    </contact>
    <investigator>
      <last_name>Maria Bell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Cincinnati</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45267</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valerie Hagood</last_name>
      <phone>513-584-5044</phone>
      <email>Val.Hagood@ucmail.uc.edu</email>
    </contact>
    <investigator>
      <last_name>Thomas Herzog, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Womens Cancer Center/Kettering Cancer Care</name>
      <address>
        <city>Kettering</city>
        <state>Ohio</state>
        <zip>45429</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wanda Caplinger</last_name>
      <phone>937-281-3900</phone>
      <email>wanda.caplinger@ketteringhealth.org</email>
    </contact>
    <investigator>
      <last_name>Thomas Reid, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Oklahoma Health Sciences Center-Stephenson Cancer Center</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hee Sun Kim-Suh</last_name>
      <phone>405-271-8777</phone>
      <email>HeeSun-Kim@ouhsc.edu</email>
    </contact>
    <investigator>
      <last_name>Laura Holman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Willamette Valley Cancer Institute and Research Center</name>
      <address>
        <city>Eugene</city>
        <state>Oregon</state>
        <zip>97401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Smith</last_name>
      <phone>541-683-5001</phone>
      <email>jessica.smith1@usoncology.com</email>
    </contact>
    <investigator>
      <last_name>Charles Anderson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Luke's University Health Network</name>
      <address>
        <city>Bethlehem</city>
        <state>Pennsylvania</state>
        <zip>18015</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diane Villasenor</last_name>
      <phone>484-526-7409</phone>
      <email>diane.villasenor@sluhn.org</email>
    </contact>
    <investigator>
      <last_name>Nicholas Taylor, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Penn State Hershey Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wanda Neidig</last_name>
      <phone>717-531-8144</phone>
      <email>wneidig@pennstatehealth.psu.edu</email>
    </contact>
    <contact_backup>
      <last_name>Francis Miller</last_name>
      <email>fmiller3@pennstatehealth.psu.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Joshua Kesterson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linda Crossette</last_name>
      <phone>215-614-0234</phone>
      <email>Linda.Crossette@pennmedicine.upenn.edu</email>
    </contact>
    <investigator>
      <last_name>Ashley Haggerty, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fox Chase Cancer Center</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brittney Cirone</last_name>
      <phone>215-728-1133</phone>
      <email>Brittney.Cirone@fccc.edu</email>
    </contact>
    <investigator>
      <last_name>Christina Chu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>West Penn Hospital</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Siobhan Guyach</last_name>
      <phone>412-578-4517</phone>
      <email>siobhan.guyach@ahn.org</email>
    </contact>
    <investigator>
      <last_name>Thomas Krivak, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>GHS Cancer Institute</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29605</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gina Norris</last_name>
      <phone>864-242-2762</phone>
      <email>gnorris@ghs.org</email>
    </contact>
    <investigator>
      <last_name>Jeffrey Elder, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sanford Clinical Research</name>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <zip>57104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashley Johnson</last_name>
      <phone>605-312-3343</phone>
      <email>ashley.johnson9@sanfordhealth.org</email>
    </contact>
    <investigator>
      <last_name>Maria Bell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Texas Oncology, Austin Central - USO</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78731</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kaelyn Kappeler</last_name>
      <phone>512-427-9400</phone>
      <email>Kaelyn.kappeler@usoncology.com</email>
    </contact>
    <investigator>
      <last_name>Michael G Teneriello, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Memorial Hermann</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sonia Robazetti</last_name>
      <phone>832-217-5571</phone>
      <email>sonia.c.robazetti@uth.tmc.edu</email>
    </contact>
    <investigator>
      <last_name>Joseph Lucci, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UT Health</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Perry</last_name>
      <phone>210-450-8817</phone>
      <email>perryj5@uthscsa.edu</email>
    </contact>
    <investigator>
      <last_name>Georgia McCann, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universtiy of Vermont</name>
      <address>
        <city>Burlington</city>
        <state>Vermont</state>
        <zip>05405</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karen Wilson</last_name>
      <phone>802-565-4101</phone>
      <email>Karen.m.wilson@uvm.edu</email>
    </contact>
    <investigator>
      <last_name>Cheung Wong, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MultiCare Institute for Research &amp; Innovation</name>
      <address>
        <city>Tacoma</city>
        <state>Washington</state>
        <zip>98405</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Danielle Wahinekapu</last_name>
      <phone>253-403-5264</phone>
      <email>dwahinekapu@multicare.org</email>
    </contact>
    <investigator>
      <last_name>Wafic Massry, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Wisconsin</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53792</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claire Kostechka</last_name>
      <phone>608-263-2079</phone>
      <email>kostechka@wisc.edu</email>
    </contact>
    <investigator>
      <last_name>Lisa Barroilhet, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Marshfield Clinic Cancer Care &amp; Research Center</name>
      <address>
        <city>Marshfield</city>
        <state>Wisconsin</state>
        <zip>54449</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cheryl Revels</last_name>
      <phone>715-389-4177</phone>
      <email>Revels.cheryl@marshfieldclinic.org</email>
    </contact>
    <investigator>
      <last_name>Arlene Gayle, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Froedtert and Medical College of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carli Jarman</last_name>
      <phone>414-805-6647</phone>
      <email>cjarman@mcw.edu</email>
    </contact>
    <investigator>
      <last_name>William Bradley, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rambam Medical Center</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tali Lifshits-Gritzman</last_name>
      <phone>972-4-7771796</phone>
      <email>gyn_onco@rambam.health.gov.il</email>
    </contact>
    <investigator>
      <last_name>Amnon Amit, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hadassah Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <zip>91120</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Noa Kamin</last_name>
      <phone>+972-2-6776709</phone>
      <email>noakamin@hadassah.org.il</email>
    </contact>
    <investigator>
      <last_name>David Edelmann, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shaare Tzedek Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dalia Sherizen</last_name>
      <phone>972-2-6555424</phone>
      <email>daliash@szmc.org.il</email>
    </contact>
    <investigator>
      <last_name>Ora Rosengarten, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rabin Medical Center</name>
      <address>
        <city>Petach Tikva</city>
        <zip>49100</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eyal Peretz</last_name>
      <phone>972-3-9377428</phone>
      <email>EyalPe@clalit.org.il</email>
    </contact>
    <investigator>
      <last_name>Daliah Tsoref, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chaim Sheba Medical Center</name>
      <address>
        <city>Ramat Gan</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yona Gilady</last_name>
      <phone>03-5309091</phone>
      <email>yona.gilady@sheba.health.gov.il</email>
    </contact>
    <investigator>
      <last_name>Ronnie Shapira-Frommer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kaplan Medical Center, Department of Oncology</name>
      <address>
        <city>Rehovot</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elinor Dahari</last_name>
      <phone>972-8-9441007</phone>
      <email>elinorda@clalit.org.il</email>
    </contact>
    <investigator>
      <last_name>Adelya Yachnin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Aichi Cancer Center</name>
      <address>
        <city>Nagoya</city>
        <state>Aichi</state>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>National Cancer Center Hospital East</name>
      <address>
        <city>Kashiwa</city>
        <state>Chiba</state>
        <zip>277-8577</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ehime University Hospital</name>
      <address>
        <city>Tōon</city>
        <state>Ehime</state>
        <zip>791-0295</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>NA NA</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kurume University Hospital</name>
      <address>
        <city>Kurume</city>
        <state>Fukuoka</state>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Sapporo Medical University Hospital</name>
      <address>
        <city>Sapporo</city>
        <state>Hokkaido</state>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Iwate Medical University Hospital</name>
      <address>
        <city>Shiwa-gun</city>
        <state>Iwate</state>
        <zip>028-3695</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Tohoku University Hospital</name>
      <address>
        <city>Sendai</city>
        <state>Myagi</state>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>National Defense Medical College Hospital</name>
      <address>
        <city>Tokorozawa</city>
        <state>Saitama</state>
        <zip>359-8513</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>National Cancer Center Hospital</name>
      <address>
        <city>Chuo-ku</city>
        <state>Tokyo</state>
        <zip>104-0045</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>NA NA</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cancer Institute Hospital of Japanese Foundation for Cancer Research</name>
      <address>
        <city>Koto</city>
        <state>Tokyo</state>
        <zip>135-8550</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Niigata Cancer Center Hospital</name>
      <address>
        <city>Niigata</city>
        <zip>951-8566</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hokkaido University Hospital</name>
      <address>
        <city>Sapporo</city>
        <zip>060-8648</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centrum Badan Klinicznych Jagiellonskiego Centrum Innowacji</name>
      <address>
        <city>Kraków</city>
        <zip>30-348</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Iwona Żaba</last_name>
      <phone>+48 691 955 008</phone>
      <email>iwona.zaba@jci.pl</email>
    </contact>
    <investigator>
      <last_name>Pawel Blecharz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Samodzielny Publiczny Zaklad Opieki Zdrowotnej MSWiA z Warminsko-Mazurskim Centrum Onkologii w Olsztynie</name>
      <address>
        <city>Olsztyn</city>
        <zip>10-228</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hanna Madej-Smiechowska</last_name>
      <phone>+48 89 539 87 56</phone>
      <email>hanna.madej-smiechowska@poliklinika.net</email>
    </contact>
    <investigator>
      <last_name>Lubomir Bodnar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MedPolonia Sp. z o.o.</name>
      <address>
        <city>Poznań</city>
        <zip>60-375</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Boryczka</last_name>
      <phone>+48 513 155 613</phone>
      <email>anna.boryczka@medpolonia.com.pl</email>
    </contact>
    <investigator>
      <last_name>Rodryg Ramlau, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Parc Taulí Hospital Universitari Edifici Santa Fe, Planta 0, Sala de recerca 3</name>
      <address>
        <city>Barcelona</city>
        <zip>08208</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mercè Abad</last_name>
      <phone>00 34 93 724 00 84</phone>
      <email>mabad@tauli.cat</email>
    </contact>
    <investigator>
      <last_name>Yolanda García, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Català d'Oncologia - Hospital Duran i Reynals</name>
      <address>
        <city>Barcelona</city>
        <zip>08908</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jokin Yllera</last_name>
      <phone>00 34 93 260 73 33</phone>
      <email>jyllera_ext@iconcologia.net</email>
    </contact>
    <investigator>
      <last_name>Marta Gil, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Donostia Edificio Onkologikoa- Planta baja, Sala de Ensayos Clinicos</name>
      <address>
        <city>Donostia</city>
        <zip>20014</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>María Díez</last_name>
      <phone>0034 94332 8151</phone>
      <email>MARIA.DIEZZUBIZARRETA@osakidetza.eus</email>
    </contact>
    <investigator>
      <last_name>Cristina Churruca, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Gregorio Marañon Módulo prefabricado Oncología, Planta Baja</name>
      <address>
        <city>Madrid</city>
        <zip>28009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Estela Lopez</last_name>
      <phone>0034 914269393</phone>
      <email>stelalop@yahoo.es</email>
    </contact>
    <investigator>
      <last_name>Sara Perez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MD Anderson Cancer Center Madrid Unidad de ensayos Clinicos</name>
      <address>
        <city>Madrid</city>
        <zip>28033</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miriam Delgado</last_name>
      <phone>00 34 91 787 86 00 Ext. 2883</phone>
      <email>mirian.delgado@fundacionmdanderson.es</email>
    </contact>
    <investigator>
      <last_name>Raúl Márquez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Clínico San Carlos.</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Helena O Frade</last_name>
      <phone>00 34 91 330 30 00</phone>
      <phone_ext>7498</phone_ext>
      <email>helenaolivera.hcsc@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Antonio Casado, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen del Rocío Servicio Oncología Médica. Ensayos Clínicos. Edificio CDCA</name>
      <address>
        <city>Sevilla</city>
        <zip>41013</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabel Bernal</last_name>
      <phone>00 34 95 501 30 68</phone>
      <email>isabelb.onco.huvr@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Purificación Estévez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Instituto Valenciano de Oncología Médica (IVO</name>
      <address>
        <city>Valencia</city>
        <zip>46009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eduardo Solivares Lluch</last_name>
      <phone>0034663224875</phone>
      <email>datamanager12@fincivo.org</email>
    </contact>
    <investigator>
      <last_name>Ignacio Romero Noguera, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Consorcio Hospitalario General Universitario de Valencia Servicio de Oncología Médica - Unidad de Investigación</name>
      <address>
        <city>Valencia</city>
        <zip>46014</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Iris Ramos</last_name>
      <phone>00 34 96 313 18 00</phone>
      <phone_ext>437635</phone_ext>
      <email>ramos_iri@gva.es</email>
    </contact>
    <investigator>
      <last_name>Cristina Caballero, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
    <country>Japan</country>
    <country>Poland</country>
    <country>Spain</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.vblrx.com/</url>
    <description>VBL Therapeutics Company Website</description>
  </link>
  <link>
    <url>https://ovaltrial.com/</url>
    <description>OVAL study Website</description>
  </link>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>January 7, 2018</study_first_submitted>
  <study_first_submitted_qc>January 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 12, 2018</study_first_posted>
  <last_update_submitted>October 10, 2021</last_update_submitted>
  <last_update_submitted_qc>October 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Recurrent Ovarian cancer</keyword>
  <keyword>Platinum resistant ovarian cancer</keyword>
  <keyword>Ovarian cancer</keyword>
  <keyword>Ovarian carcinoma</keyword>
  <keyword>Epithelial ovarian cancer</keyword>
  <keyword>paclitaxel</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ovarian Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Ovarian Epithelial</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Paclitaxel</mesh_term>
    <mesh_term>Albumin-Bound Paclitaxel</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

